FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA granted supplemental approval for palonosetron hydrochloride from Cipla USA Inc. under NDA 021372.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)